head-and-neck-cancer

Documents about head-and-neck-cancer

• Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma#995309ClinicalTrials.gov
• Maitland Mobilization and Scapular Stabilization Shoulder Dysfunction#904370ClinicalTrials.gov
• MRG FU With Radiotherapy for Palliation of H&N Cancer#893848ClinicalTrials.gov
• Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy#826190ClinicalTrials.gov
• Creation of the BioBank, Early Detection and Discovery Biomarkers#803068ClinicalTrials.gov
• Hypnosis and Meditation for Cancer Pain#848501ClinicalTrials.gov
• Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium#195840HAL (France)
• Burden of head and neck cancers in five East Asian countries from 1990 to 2023: Observation, comparison, and forecast from the global burden of disease study 2023#187805PLOS
• Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer#146268ClinicalTrials.gov
• Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer#838547ClinicalTrials.gov
• Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer#865681ClinicalTrials.gov
• Big Data and Models for Personalized Head and Neck Cancer Decision Support (BD2Decide)#981565ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer#238169ClinicalTrials.gov
• COPD Care Pathway Among Patients With Cancer#895387ClinicalTrials.gov
• Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors#875693ClinicalTrials.gov
• Evidence summary on non-pharmacological interventions of the radiation dermatitis in patients with head and neck cancer#4484Europe PMC
• Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer#911413ClinicalTrials.gov
• Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From Chemotherapy#918694ClinicalTrials.gov
• Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer#405201ClinicalTrials.gov
• ITIL-168 in Advanced Solid Tumors#325305ClinicalTrials.gov
• Effect of physical therapy modalities on quality of life of head and neck cancer survivors: A systematic review with meta-analysis#948547Repositorio de Universidad Autónoma de Chile.
• Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer#143661ClinicalTrials.gov
• Pilot Study of 18F-FLT PET#1044819ClinicalTrials.gov
• Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)#870636ClinicalTrials.gov
• Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma#967820ClinicalTrials.gov
• In vitro head and neck cancer models for photodynamic and photothermal therapies#238892HAL (France)
• Ixovex-1 Single Agent and Combination Therapy#900048ClinicalTrials.gov
• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#249594ClinicalTrials.gov
• A Trial Comparing Two Modalities of Prophylactic Nutritional Support During Treatment for Head and Neck Cancer#849712ClinicalTrials.gov
• This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091#897205ClinicalTrials.gov
• Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers#869628ClinicalTrials.gov
• Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)#874410ClinicalTrials.gov
• Nutritional management and oral health-related outcomes in head and neck cancer treated with radiotherapy or chemoradiotherapy: a systematic review#137412HAL (France)
• A Prospective Longitudinal Cohort Study Looking at the Difference in Carotid Intima-medial Thickness Between Irradiated and Unirradiated Carotid Arteries in Patients With Head and Neck Cancer#851606ClinicalTrials.gov
• Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors#966551ClinicalTrials.gov
• Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response#426758ClinicalTrials.gov
• Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy#857104ClinicalTrials.gov
• Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients#862517ClinicalTrials.gov
• Molecular changes in the multistage pathogenesis of head and neck cancer#129202PMC Full-Text (OAI)
• Personalized Rehabilitation With Organ-Preserving Robotic RESA in Head and Neck Cancer#914083ClinicalTrials.gov
• Validating cancer-specific and generic quality of life (QoL) instruments among patients with head and neck cancers: incorporating the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck Module with generic QoL instruments.#288616NCBI PubMed Central
• Optional Sub-study to Intraoperative Imaging With ICG Registry#843472ClinicalTrials.gov
• BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer#838353ClinicalTrials.gov
• Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)#889921ClinicalTrials.gov
• Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol#643355HAL (France)
• Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma#841955ClinicalTrials.gov
• Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck#913177ClinicalTrials.gov
• Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC#918192ClinicalTrials.gov
• Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）#1045652ClinicalTrials.gov
• Prospective PROM and PREM Analysis Demonstrating Specification Advantage and Language Barriers#1032305ClinicalTrials.gov